CDKN2A and central nervous system cancer: Indeed, inactivation of TP53, INK4a/ARF locus, PTEN, and NF1 tumor suppressors or activation of EGFR/PDGFR/PI3K oncogenic pathways in NSCs induces high-grade gliomas (17).